Skip to main content
. 2021 Jun 8;22(3):161–171. doi: 10.1038/s41435-021-00137-5

Table 2.

Single-nucleotide polymorphisms (SNPs) used to define blood antigen phenotypes of participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Blood type Chromosome:position SNP [6366] Nucleotide Weighted prevalence (%)
ABO
A1 Ref Ref Ref 11.5
A2 9:133256264 rs1053878 A 7.9
B 9:133256205/133257486 rs7853989/rs8176720 G/G 17.3
O (null) 9:133257521-133257522 rs8176719 Del 63.3
Auburger
A Ref Ref Ref 66.4
B 19:44819487 rs1135062 G 33.6
Colton
A Ref Ref Ref 96.4
B 7:30912043 rs28362692 T 3.6
Dombrock
A Ref Ref Ref 69.8
B 12:14840505 rs11276 T 30.2
Duffy
A Ref Ref Ref 57.4
B 1:159205564 rs12075 A 40.8
x 1:159205704 rs34599082 T 1.8
Null 1:159204893 rs2814778 C <0.1
Kell
k Ref Ref Ref 94.7
K 7:142957921 rs8176058 A 5.3
Kidd
A Ref Ref Ref 49.8
B 18:45739554 rs1058396 A 50.2
Knops
A Ref Ref Ref 97.4
B 1:207609424 rs41274768 G 2.6
Lewis
A Ref Ref Ref 32.1
le1 (Null) 19:5844781/5844332 rs28362459/rs3745635 C/T 6.5
le2 (Null) 19:5844781/5843773 rs28362459/rs3894326 C/T 3.4
B 19:48703417 rs601338 G 58
Lutheran
A Ref Ref Ref 96.5
B 19:44812188 rs28399653 G 3.5
RhE
E Ref Ref Ref 86.1
e 1:25390874 rs609320 G 13.9
Secretor
Se Ref Ref Ref 58
se (null) 19:48703417 rs601338 A 42